AI assistant
Sending…
Cabaletta Bio, Inc. — Director's Dealing 2022
Oct 19, 2022
33628_dirs_2022-10-18_fdcb8132-3eb6-442e-ab8f-affe0c66842e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2022-10-18
Reporting Person: Bollard Catherine (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-10-18 | Common Stock | P | 1000 | $0.9935 | Acquired | 1000 | Direct |
More from Cabaletta Bio, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Mar 23